Your browser doesn't support javascript.
loading
Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study.
Van Voorhees, A S; Stein Gold, L; Lebwohl, M; Strober, B; Sofen, H; Papp, K; Bagel, J; Zhang, Z; Paris, M; Wang, Y.
Afiliação
  • Van Voorhees AS; Eastern Virginia Medical School, Norfolk, VA, USA.
  • Stein Gold L; Henry Ford Health System, West Bloomfield, MI, USA.
  • Lebwohl M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Strober B; Yale University, New Haven, CT, USA.
  • Sofen H; Central Connecticut Dermatology, Cromwell, CT, USA.
  • Papp K; UCLA School of Medicine, Los Angeles, CA, USA.
  • Bagel J; Probity Medical Research, Waterloo, ON, Canada.
  • Zhang Z; K Papp Clinical Research, Waterloo, ON, Canada.
  • Paris M; Psoriasis Treatment Center of Central New Jersey, East Windsor, NJ, USA.
  • Wang Y; Amgen Inc., Thousand Oaks, CA, USA.
Br J Dermatol ; 185(4): 840-842, 2021 10.
Article em En | MEDLINE | ID: mdl-33763874
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article